Ocular demodicosis as a potential cause of pediatric blepharoconjunctivitis

Cornea

Volumn 29, Issue 12, 2010, Pages 1386-1391

  Liang, Lingyi ^a,b   Safran, Steve ^c   Gao, Yingying ^d   Sheha, Hosam ^a,e   Raju, V K ^a   Tseng, Scheffer C G ^a  

^a OCULAR SURFACE CENTER   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c Steve G Safran MD Clinics   (United States)

^d FUJIAN MEDICAL UNIVERSITY   (China)

^e RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

Author keywords

blepharoconjunctivitis; Demodex; pediatric; tea tree oil

Indexed keywords

TEA TREE OIL;

ARTICLE; BLEPHAROCONJUNCTIVITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONJUNCTIVITIS; DANDRUFF; DEMODEX; DEMODICOSIS; DRUG TREATMENT FAILURE; EYE INFECTION; EYELASH; FEMALE; FOLLOW UP; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BLEPHARITIS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CONJUNCTIVITIS; EYE INFECTIONS, PARASITIC; EYELASHES; FEMALE; HUMANS; MALE; MASSAGE; MITE INFESTATIONS; MITES; RETROSPECTIVE STUDIES; TEA TREE OIL;

EID: 78650517730     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181e2eac5     Document Type: Article

References (34)

1. Farpour B, McClellan KA. Diagnosis and management of chronic blepharokeratoconjunctivitis in children. J Pediatr Ophthalmol Strabismus. 2001;38:207-212.
2. McCulley JP. Blepharoconjunctivitis. Int Ophthalmol Clin. 1984;24: 65-77.
3. Hammersmith KM, Cohen EJ, Blake TD, et al. Blepharokeratoconjunctivitis in children. Arch Ophthalmol. 2005;123:1667-1670.
4. Viswalingam M, Rauz S, Morlet N, et al. Blepharokeratoconjunctivitis in children: Diagnosis and treatment. Br J Ophthalmol. 2005;89:400-403.
5. Jones SM,Weinstein JM, Cumberland P, et al. Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis. Ophthalmology. 2007;114:2271-2280.
6. DayalY,Venkateswarlu K, Mahajan VM. Blepharoconjunctivitis-a clinico microbiological and experimental study. Indian J Ophthalmol. 1985;33: 3-8.
7. Meisler DM, Raizman MB, Traboulsi EI. Oral erythromycin treatment for childhood blepharokeratitis. J AAPOS. 2000;4:379-380.
8. Gao YY, Di Pascuale MA, Elizondo A, et al. Clinical treatment of ocular demodecosis by lid scrub with tea tree oil. Cornea. 2007;26:136-143.
9. Kheirkhah A, Casas V, Li W, et al. Corneal manifestations of ocular Demodex infestation. Am J Ophthalmol. 2007;143:743-749.
10. English FP, Nutting WB. Demodicosis of ophthalmic concern. Am J Ophthalmol. 1981;91:362-372.
11. Gao Y-Y, Di Pascuale MA, LiW, et al. High prevalence of ocular Demodex in lashes with cylindrical dandruffs. Invest Ophthalmol Vis Sci. 2005;46: 3089-3094.
12. Coston TO. Demodex folliculorum blepharitis. Trans Am Ophthalmol Soc. 1967;65:361-392.
13. Norn MS. Incidence of Demodex folliculorum on skin of lids and nose. Acta Ophthalmol (Copenh). 1982;60:575-583.
14. Czepita D, Kuzna-Grygiel W, Kosik-Bogacka D. Investigations on the occurrence as well as the role of Demodex follicuforum and Demodex brevis in the pathogensis of blepharitis. Klin Oczna. 2005;107:80-82.
15. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: A preliminary report. J Am Acad Dermatol. 2001;44:995-998.
16. Lubbe J, Stucky L, Saurat JH. Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream. Dermatology. 2003;207:204-205.
17. Morras PG, Santos SP, Imedio IL, et al. Rosacea-like demodicidosis in an immunocompromised child. Pediatr Dermatol. 2003;20:28-30.
18. Ashack RJ, Frost ML, Norins AL. Papular pruritic eruption of Demodex folliculitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1989;21:306-307.
19. Dominey A, Rosen T, Tschen J. Papulonodular demodicidosis associated with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1989; 20:197-201.
20. Ivy SP, Mackall CL, Gore L, et al. Demodicidosis in childhood acute lymphoblastic leukemia; an opportunistic infection occurring with immunosuppression. J Pediatr. 1995;127:751-754.
21. Nakagawa T, Sasaki M, Fujita K, et al. Demodex folliculitis on the trunk of a patient with mycosis fungoides. Clin Exp Dermatol. 1996;21: 148-150.
22. Farina MC, Requena L, Sarasa JL, et al. Spinulosis of the face as a manifestation of demodicidosis. Br J Dermatol. 1998;138:901-903.
23. Jansen T, Kastner U, Kreuter A, et al. Rosacea-like demodicidosis associated with acquired immunodeficiency syndrome. Br J Dermatol. 2001;144:139-142.
24. Kheirkhah A, Blanco G, Casas V, et al. Fluorescein dye improves microscopic evaluation and counting of Demodex in blepharitis with cylindrical dandruff. Cornea. 2007;26:697-700.
25. Gao Y-Y, Di Pascuale MA, LiW, et al. In vitro and in vivo killing of ocular Demodex by tea tree oil. Br J Ophthalmol. 2005;89:1468-1473.
26. Heacock CE. Clinical manifestations of demodicosis. J Am Optom Assoc. 1986;57:914-919.
27. Kamoun B, Fourati M, Feki J, et al. Blepharitis due to Demodex: Myth or reality? J Fr Ophtalmol. 1999;22:525-527.
28. Turk M, Ozturk I, Sener AG, et al. Comparison of incidence of Demodex folliculorum on the eyelash follicule in normal people and blepharitis patients. Turkiye Parazitol Derg. 2007;31:296-297.
29. Hom MM, Martinson JR, Knapp LL, et al. Prevalence of meibomian gland dysfunction. Optom Vis Sci. 1990;67:710-712.
30. Mustafa TA, Oriafage IH. Three methods of treatment of chalazia in children. Saudi Med J. 2001;22:968-972.
31. Kaimbo Wa KD, Nkidiaka MC. Intralesional corticosteroid injection in the treatment of chalazion. J Fr Ophtalmol. 2004;27:149-153.
32. Akpek EK, Merchant A, Pinar V, et al. Ocular rosacea: Patient characteristics and follow-up. Ophthalmology. 1997;104:1863-1867.
33. English FP, Iwamoto T, Darrell RW, et al. The vector potential of Demodex folliculorum. Arch Ophthalmol. 1970;84:83-85.
34. Clifford CW, Fulk GW. Association of diabetes, lash loss, and Staphylococcus aureus with infestation of eyelids by Demodex folliculorum (Acari: Demodicidae). J Med Entomol. 1990;27:467-470.